Stay updated with breaking news from Ohnson Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jun. 11—Get a shot and receive a voucher to take some shots at the shooting range during a Greene County coronavirus vaccination clinic. Greene County Public Health partnered with the Ohio Division of Wildlife to offer a free day at the shooting range for those vaccinated at the "Shoot for a Shot" clinic. The clinic is Saturday from 10 a.m. to 2 p.m. at the Spring Valley Shooting Range and ...
The European Medicines Agency (EMA) did not say how many shots were affected, but Reuters has reported it involves millions of doses, making it harder for J&J to meet a target of delivering 55 million to Europe by end of June. J&J did not immediately respond to Reuters queries. The EMA said it was aware a batch of the active substance for J&J's COVID-19 vaccine had been contaminated in April with materials for another vaccine made at the site in Maryland owned by Emergent Biosolutions.
Trevor Noah and Jimmy Kimmel credit U.S. anti-vaxxers for Biden's big global COVID-19 vaccine donation
The European Union does not expect Johnson & Johnson will be able to deliver 55 million COVID-19 vaccine doses it had committed to shipping to the bloc by the end of June, an EU official said on Friday. The EU had previously said that it was confident the U.S. pharmaceutical giant could meet its commitments. The position has changed after the European drugs regulator earlier on Friday said J&J doses sent to Europe from a factory in the United States would not be used out of precaution after a case of contamination.
A further 10 million J&J doses would be allowed to be distributed with a warning that there was no guarantee contract manufacturer Emergent BioSolutions Inc had followed proper practices, the newspaper said. Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that multiple other batches were not suitable for use and that others were being evaluated. The agency said it was not yet ready to authorize Emergent's plant for manufacturing the J&J vaccine.